Ausgabe 2/2020
Inhalt (25 Artikel)
Circumnavigating the challenges of COVID-19 in oncology
- editorial
Thorsten Fuereder, Eberhard Gunsilius, Rupert Bartsch, Wolfgang Hilbe
ESMO 2019—personal non-small lung cancer highlights
- Open Access
- short review
Lena Horvath, Andreas Pircher
The role of surgery in soft tissue sarcoma: Can we improve outcome and function towards sporting activities?
- Open Access
- short review
Reinhard Windhager, Gerhard M. Hobusch
Metastatic sarcoma: tailored strategies for a heterogeneous disease
- short review
Massimiliano Grassi, Andrea Spagnoletti, Alberto Puccini
Screening for ovarian cancer: is there still hope?
- Open Access
- short review
Stefanie Aust, Veronika Seebacher-Shariat
Ovarian cancer surgery
- Open Access
- short review
Richard Schwameis, Valentina Paspalj, Marlene Kranawetter, Stephan Polterauer
PARP inhibitors in the treatment of ovarian cancer
- Open Access
- review
Alain G. Zeimet, Verena Wieser, Katharina Knoll, Daniel Reimer, Christian Marth
Current state and perspectives of checkpoint inhibitors in ovarian cancer treatment
- Open Access
- short review
Thomas Bartl, Valentina Paspalj, Stephan Polterauer, Christoph Grimm
Thermal ablation—an option in curative treatment of HCC
- Open Access
- short review
Daniel Putzer, Peter Schullian, Gernot Eberle, Reto Josef Bale
The intestinal microbiota and hepatocellular carcinoma
- Open Access
- review
Maria Effenberger, Herbert Tilg
PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia
- Open Access
- original report
Georgi Mihaylov, Barbara Skopec, Zuzana Sninska, Nikolai Tzvetkov, Olga Cerna, Vladlen Ivanushkin, Daniela Niepel, Katja Björklöf, Peter Černelč
Different CALR mutation subtypes in essential thrombocythemia and primary myelofibrosis patients without JAK2 mutation
- original report
Layla M. Saleh, Reem Algamal, Hanaa Abd Elmasseh, Emily Barber, Hasan Abdel-ghaffar
